TRUOG PETER has a total of 11 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PRO NEURON INC, GEM PHARMACEUTICALS LLC and IMMUNE SYSTEM REGULATION HOLDING AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Fermentation | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Truog Peter | 11 |
#2 | Rothlisberger Peter | 2 |
#3 | Roethlisberger Peter | 1 |
#4 | Roethlisberger P | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019197015A1 | Composition comprising 4-phenylbutyric acid derivatives & opioids | |
WO2016165770A1 | 4-phenylbutyric acid derivatives | |
US2006045912A1 | 4-phenylbutyric acid controlled-release formulations for therapeutic use | |
CA2208780A1 | Antitumor and anticholesterol preparations comprising lipoteichoic acid lta-t of streptococcus sp dsm 8747 |